Biogen will invest $2 billion more in its existing manufacturing plants in North Carolina, the drugmaker said on Monday, as ...

Eli Lilly's Tirzepatide has won over Novo's Semaglutide in the GLP-1 race in both glucose control and weight loss, driving market share gains. Retatrutide and Orforglipron signal a similar Next-Gen ...

Penn's Kiran Musunuru spoke with The Inquirer about the future of CRISPR technology.

David Mooney, who most recently served as Chief of Cyber Protective Services at the Cybersecurity and Infrastructure Security ...

Industry-Wide Tariffs Loom Over the Healthcare Sector. Here Are 2 Stocks That Can Weather the Storm.

Pfizer and Novo Nordisk have underperformed the market over the past year. Pharmaceutical giants Pfizer (NYSE: PFE) and Novo ...

In a video shared to TikTok via her page, @lucy52915, which has racked up more than 750,000 views, she revealed pictures of ...

The largest healthcare stocks by market capitalization are undergoing significant sell-offs. UnitedHealth is still a large ...

On Thursday’s episode of Mad Money, host Jim Cramer turned his focus to large-cap stocks that surged by $10 or more in a single day.

A recent spot check revealed that drugstores in Nairobi, including online pharmacies, are selling more insulin than in ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030.

Scroll through any hoops-heavy feed on X, and you’ll see it. The post Our Fans Approve Blockbuster All-Star in Indy, But All ...